Natural Polymers Based Biocompatible Nanomedicines for Targeting Colon Cancer: Prospects and Challenges

Area of Science:

• Biomaterials Science
• Nanomedicine
• Oncology

Background:

• Natural polymers are increasingly explored for biocompatible nanomedicines.
• These biopolymers offer biodegradability, low immunogenicity, and easy functionalization for targeted colon cancer therapy.
• Nanoparticles derived from natural polymers can enhance therapeutic delivery to tumors, reducing systemic toxicity.

Purpose of the Study:

• To review the current status of natural polymer-based nanomedicines for colon cancer treatment.
• To evaluate their unique properties, therapeutic potential, and challenges.
• To highlight novel technologies addressing these challenges for clinical success.

Main Methods:

• Literature review of natural polymer-based nanomedicines in colon cancer therapy.
• Analysis of nanoparticle design complexities, synthesis, and scale-up issues.
• Evaluation of clinical translation hurdles, including EPR heterogeneity and preclinical model limitations.

Main Results:

• Natural polymers provide a versatile platform for targeted colon cancer nanomedicines.
• Challenges include complex nanoparticle design, manufacturing scale-up, and unpredictable therapeutic responses due to EPR heterogeneity.
• Potential cytotoxicity necessitates advanced preclinical safety and efficacy models.

Conclusions:

• Natural polymer-based nanomedicines hold significant promise for colon cancer treatment.
• Overcoming challenges in design, production, and personalized treatment is crucial for clinical translation.
• Emerging technologies like microfluidics offer scalable and effective solutions for nanomedicine delivery.